HOME >> BIOLOGY >> NEWS
The forgotten methane source

In the last few years, more and more research has focused on the biosphere; particularly, on how gases which influence the climate are exchanged between the biosphere and atmosphere. Researchers from the Max Planck Institute for Nuclear Physics have now carefully analysed which organic gases are emitted from plants. They made the surprising discovery that plants release methane, a greenhouse gas - and this goes against all previous assumptions. Equally surprising was that methane formation is not hindered by the presence of oxygen. This discovery is important not just for plant researchers but also for understanding the connection between global warming and increased greenhouse gas production (Nature, January 12, 2006).

Methane is the greenhouse gas which has the second greatest effect on climate, after carbon dioxide. The concentration of methane in the atmosphere has almost tripled in the last 150 years. Methane is best known as natural gas, currently an important energy source. Nonetheless, only part of the methane uptake in the atmosphere is due to industrial activities connected to energy production and use. More important for the increase of methane in the atmosphere is the increase in so-called "biogenic" sources, e.g., rice cultivation or domestic ruminants related to the rise in the world's population. Nowadays, methane in the atmosphere in fact is largely of biogenic origin.

Until now, it has been assumed that biogenic methane is formed anaerobically, that is, via micro-organisms and in the absence of oxygen. In this way, acetate or hydrogen and carbon dioxide are transformed into methane; they themselves are created in the anaerobic decomposition of organic materials. The largest anoxic sources of methane are wetlands and rice fields, as well as the digestion of ruminants and termites, waste disposal sites, and the gas produced by sewage treatment plants. According to previous estimates, these sources make up two-thirds of the 600 million
'"/>

Contact: Dr. Frank Keppler
frank.keppler@mpi-hd.mpg.de
49-622-151-6575
Max-Planck-Gesellschaft
11-Jan-2006


Page: 1 2 3

Related biology news :

1. Gone but not forgotten
2. Plants do not emit methane
3. Explaining the methane mystery
4. Sequencing the genome of a new kind of methane producer
5. LUCA technologies confirms real-time methane generation
6. Hydrogen and methane provide raw energy for life at Lost City
7. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate
8. Bright future for nano-sized light source
9. Pointing a finger at the source of fecal bacteria
10. Alien plants attack using resource conservation as weapon, researchers say
11. Supermap of avian flu yields new info on source/spread

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The forgotten methane source

(Date:3/23/2015)... LOS ANGELES , March 23, 2015  In ... in Federal fraud case conviction losses. This figure accounts ... fraud, which, according to The Nilson Report, exceeds $11 ... an investigative tool after a crime has occurred. Investor ... Agent and polygraph expert Joe Paolella partnered ...
(Date:3/20/2015)... , Mar. 19, 2015 Research and Markets ... "Iris Biometrics - Global Strategic Business Report" report ... markets for Iris Biometrics in US$ Thousands. The report provides ... , Japan , Europe ... , and Latin America . ...
(Date:3/17/2015)...  MecklerMedia Corporation (OTCQX: MECK) announced its ... ever held in New York City ... 2015 at the Javits Convention Center. ... Acorn Product Development; Axis NJ; c-Link Systems; CoroWare; ... NewBotic Corporation; Neya Systems LLC; Reliabotics; RoboKind; RocketFarm ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
(Date:3/30/2015)... 2015 CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... commercial focus on China , announced ... has approved the Company,s application to conduct a Phase ... (OCCC) patients for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... CARDIFF, UK, and BELLINGHAM, Washington, USA (PRWEB) March 29, ... energy projects in Europe and the United States and ... programme highlights planned for SPIE Optics + Optoelectronics ... will feature over 700 technical presentations in 17 conferences ... international society for optics and photonics , the event ...
(Date:3/30/2015)... MADISON, Wis. , March 30, 2015  FUJIFILM ... ("Fujifilm") and Cellular Dynamics International, Inc. (CEO: Robert ... leading developer and manufacturer of fully functioning human cells ... the two companies have entered into a definitive agreement ... offer to be followed by a second step merger. ...
(Date:3/29/2015)... March 29, 2015 As a symbol ... required by our pharmaceutical manufacturing clients, Whitehouse Laboratories is ... of the Berkenstock Race Team for the 2015 race ... only speed, but a strong sense of precision and ... lead to success in the quality control testing laboratory. ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 2Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 4Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 5Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 6Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 7Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 8Whitehouse Laboratories Reaffirms Commitment to Speedy Results – Renews Sponsorship of Berkenstock Racing Team 2
Cached News: